Although debatable, thrombocytopenia causes a physiologic compensatory secretion of thrombopoietin that seems to correlate with other prognostic biomarkers including IGHV mutation status, ZAP 70 and CD38 [17,18]. This evidence concerns the gene CD38 and Thrombocytopenia.